ES2157197T3 - Expresion de receptores acoplados a una proteina g en levadura. - Google Patents

Expresion de receptores acoplados a una proteina g en levadura.

Info

Publication number
ES2157197T3
ES2157197T3 ES91916216T ES91916216T ES2157197T3 ES 2157197 T3 ES2157197 T3 ES 2157197T3 ES 91916216 T ES91916216 T ES 91916216T ES 91916216 T ES91916216 T ES 91916216T ES 2157197 T3 ES2157197 T3 ES 2157197T3
Authority
ES
Spain
Prior art keywords
protein
dna
alpha
sequence
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91916216T
Other languages
English (en)
Inventor
Klim King
Henrik G Dohlman
Marc G Caron
Robert J Lefkowitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke University
Original Assignee
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24326283&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2157197(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Duke University filed Critical Duke University
Application granted granted Critical
Publication of ES2157197T3 publication Critical patent/ES2157197T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE PRESENTA UNA CELULA DE LEVADURA TRANSFORMADA QUE CONTIENE UNA PRIMERA SECUENCIA DE DNA HOMOLOGO QUE CODIFICA UN RECEPTOR ACOPLADO A LA PROTEINA G DE UN MAMIFERO Y UNA SEGUNDA SECUENCIA HETEROLOGA DE DNA QUE CODIFICA UNA SUBUNIDAD (ALFA) DE MAMIFERO. LA PRIMERA Y LA SEGUNDA SECUENCIA HETEROLOGA DE DNA ES CAPAZ DE EXPRESARSE EN LA CELULA, PERO LA CELULA ES INCAPAZ DE EXPRESAR UNA SUBUNIDAD (ALFA) DE LA PROTEINA G ENDOGENA (G(ALFA) DE LA LEVADURA). LAS CELULAS SON UTILES PARA FILTRAR COMPUESTOS QUE SEAN ACEPTADOS POR LA PROPORCION DE DISOCIACION DE G(ALFA) A PARTIR DE G(BETA)GAMMA EN UNA CELULA. TAMBIEN SE PRESENTA UN NUEVO VECTOR DE EXPRESION DE DNA UTIL PARA OBTENER CELULAS COMO LAS DESCRITAS ANTERIORMENTE. EL VECTOR CONTIENE UN PRIMER SEGMENTO QUE CONTIENE AL MENOS UN FRAGMENTO DE FRECUENCIA QUE CODIFICA EL AMINO TERMINAL DEL EXTREMO DEL RECEPTOR ACOPLADO DE LA PROTEINA G DE LA LEVADURA. UN SEGUNDO SEGMENTO SE SITUA DEBAJO DEL PRIMER SEGMENTO (Y EN UNA ESTRUCTURA DE LECTURA COMPUESTA CONEL MISMO), COMPRENDIENDO EL SEGUNDO SEGMENTO UNA SECUENCIA DE DNA QUE CODIFICA UN RECEPTOR APROPIADO A LA PROTEINA G HETEROLOGA.
ES91916216T 1990-09-13 1991-09-12 Expresion de receptores acoplados a una proteina g en levadura. Expired - Lifetime ES2157197T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58171490A 1990-09-13 1990-09-13

Publications (1)

Publication Number Publication Date
ES2157197T3 true ES2157197T3 (es) 2001-08-16

Family

ID=24326283

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91916216T Expired - Lifetime ES2157197T3 (es) 1990-09-13 1991-09-12 Expresion de receptores acoplados a una proteina g en levadura.

Country Status (12)

Country Link
US (6) US5482835A (es)
EP (2) EP0548165B1 (es)
JP (3) JP3348406B2 (es)
AT (1) ATE199391T1 (es)
AU (1) AU652576B2 (es)
CA (1) CA2092717C (es)
DE (1) DE69132546T2 (es)
DK (1) DK0548165T3 (es)
ES (1) ES2157197T3 (es)
GR (1) GR3035937T3 (es)
IE (2) IE20020110A1 (es)
WO (1) WO1992005244A1 (es)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2628750B1 (fr) * 1988-03-21 1991-11-08 Pasteur Institut Vecteur modifie par une sequence codant pour une sequence d'acides amines contenue dans une proteine de mammifere ayant une activite biologique de recepteur membranaire
US6080540A (en) 1990-04-20 2000-06-27 Cold Spring Harbor Laboratory Cloning of mammalian genes in microbial organisms and methods for pharmacological screening
DK0548165T3 (da) 1990-09-13 2001-07-16 Univ Duke Ekspression af G-proteinkoblede receptorer i gær
US5264565A (en) * 1991-01-22 1993-11-23 Affymax Technologies, N.V. Nucleic acid encoding the D2 /Ml chimeric receptor
DE4138621A1 (de) * 1991-11-25 1993-06-17 Boehringer Ingelheim Int Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabhaengigen zellulaeren signaluebertragungsweg
US5688662A (en) * 1992-04-09 1997-11-18 Linguagen Corporation Gustducin polynucleotides, vectors, host cells and recombinant methods
US7416881B1 (en) 1993-03-31 2008-08-26 Cadus Technologies, Inc. Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US6864060B1 (en) 1993-03-31 2005-03-08 Cadus Technologies, Inc. Yeast cells expressing modified G proteins and methods of use therefor
US20030054402A1 (en) 1993-03-31 2003-03-20 Cadus Pharmaceutical Corporation Methods and compositions for identifying receptor effectors
US7235648B1 (en) 1993-03-31 2007-06-26 Cadus Technologies, Inc. Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US6255059B1 (en) 1993-03-31 2001-07-03 Cadus Pharmaceutical Corporation Methods for identifying G protein coupled receptor effectors
US5789184A (en) * 1993-03-31 1998-08-04 Cadus Pharmaceutical Corporation Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US5876951A (en) * 1993-03-31 1999-03-02 Cadus Pharmaceutical Corporation Yeast cells engineered to produce pheromone system protein surrogates and uses therefor
US6100042A (en) 1993-03-31 2000-08-08 Cadus Pharmaceutical Corporation Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
DK0692025T3 (da) * 1993-03-31 2002-02-11 Cadus Pharmaceutical Corp Gærceller, der er konstrueret således, at de producerer surrogater for proteiner i feromonsystemet, og anvendelser deraf
US6001581A (en) * 1993-06-04 1999-12-14 Sibia Neurosciences, Inc. Cation-based bioassay using human metabotropic glutamate receptors
IL110298A (en) * 1993-07-13 1999-04-11 Brann Mark Robert Identification of ligands by selective amplification of cells transfected with receptors
US5691188A (en) * 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
CA2188950C (en) * 1994-04-26 2001-07-03 James R. Broach Functional expression of mammalian adenylyl cyclase in yeast
AU6110896A (en) * 1995-06-07 1996-12-30 Cadus Pharmaceutical Corporation Expression of functional vertebrate phospholipases in yeast
EP0862614A1 (en) * 1995-09-20 1998-09-09 Molecular Geriatrics Corporation Yeast receptor and g-protein fusion protein
US5851786A (en) * 1995-09-27 1998-12-22 National Jewish Center For Immunology And Respiratory Medicine Product and process to regulate actin polymerization
WO1997046680A1 (en) 1996-06-05 1997-12-11 Chiron Corporation Dna encoding dp. 75 and a process for its use
US7329741B2 (en) * 1996-06-05 2008-02-12 Chiron Corporation Polynucleotides that hybridize to DP-75 and their use
US6083693A (en) 1996-06-14 2000-07-04 Curagen Corporation Identification and comparison of protein-protein interactions that occur in populations
AU733007B2 (en) * 1996-09-24 2001-05-03 Cadus Pharmaceutical Corporation Methods and compositions for identifying receptor effectors
US6087115A (en) * 1997-01-22 2000-07-11 Cornell Research Foundation, Inc. Methods of identifying negative antagonists for G protein coupled receptors
US6403305B1 (en) * 1997-02-06 2002-06-11 Cornell Research Foundation, Inc. Methods of identifying peptide agonists or negative antagonists of a G protein coupled receptor
US6528271B1 (en) * 1997-06-05 2003-03-04 Duke University Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
FR2764387B1 (fr) * 1997-06-05 1999-07-23 Centre Nat Rech Scient Utilisation d'une proteine fluorescente pour la detection d'interactions entre une proteine cible et son ligand
US7541151B2 (en) 1997-06-05 2009-06-02 Duke University Single-cell biosensor for the measurement of GPCR ligands in a test sample
US5891646A (en) * 1997-06-05 1999-04-06 Duke University Methods of assaying receptor activity and constructs useful in such methods
JP2001519157A (ja) * 1997-10-07 2001-10-23 ケイダス ファーマスーティカル コーポレイション 改変ｇ蛋白質を発現する酵母細胞及びそれらの利用方法
WO1999019513A2 (en) * 1997-10-10 1999-04-22 Lxr Biotechnology, Inc. Methods for detecting compounds which modulate the activity of an lpa receptor
US6485922B1 (en) 1997-10-10 2002-11-26 Atairgin Technologies, Inc. Methods for detecting compounds which modulate the activity of an LPA receptor
US6265174B1 (en) 1997-11-03 2001-07-24 Morphochem, Inc. Methods and compositions for identifying and modulating ctionprotein-interactions
GB9725462D0 (en) * 1997-12-01 1998-01-28 Smithkline Beecham Plc Novel method
US5955575A (en) * 1997-12-22 1999-09-21 Hopital Sainte-Justine Antagonists of G-protein-coupled receptor
JP2002510480A (ja) * 1998-04-03 2002-04-09 エヌピーエス ファーマシューティカルズ インコーポレーテッド Ｇ−蛋白融合受容体およびキメラｇａｂａｂ受容体
US7262280B1 (en) 1998-04-03 2007-08-28 Nps Pharmaceuticals, Inc. G-protein fusion receptors and constructs encoding same
GB9807722D0 (en) * 1998-04-08 1998-06-10 Smithkline Beecham Plc Novel compounds
US6242205B1 (en) 1998-04-24 2001-06-05 Yale University Method of detecting drug-receptor and protein-protein interactions
US6355473B1 (en) 1998-05-06 2002-03-12 Cadus Pharmaceutical Corp. Yeast cells having mutations in stp22 and uses therefor
US6733991B1 (en) * 1998-05-08 2004-05-11 Osi Pharmaceuticals, Inc. AGS proteins and nucleic acid molecules and uses therefor
US6746852B1 (en) 1998-05-08 2004-06-08 Osi Pharmaceuticals, Inc. AGS proteins and nucleic acid molecules and uses thereof
US6280934B1 (en) 1998-05-13 2001-08-28 Millennium Pharmaceuticals, Inc. Assay for agents which alter G-protein coupled receptor activity
WO1999064567A1 (de) * 1998-06-05 1999-12-16 Discovery Technologies Ltd. Transformierte zell-linien, die heterologe g-protein-gekoppelte rezeptoren exprimieren
AU4820399A (en) * 1998-06-29 2000-01-17 Hyseq, Inc. A chemokine receptor obtained from a cdna library of fetal liver-spleen
US7081360B2 (en) * 1998-07-28 2006-07-25 Cadus Technologies, Inc. Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties
US7273747B2 (en) 1998-08-27 2007-09-25 Cadus Technologies, Inc. Cell having amplified signal transduction pathway responses and uses therefor
US7094593B1 (en) * 1998-09-01 2006-08-22 Basf Aktiengesellschaft Method for improving the function of heterologous G protein-coupled receptors
US6251605B1 (en) 1998-10-27 2001-06-26 Cadus Pharmaceutical Corporation Yeast cells having mutations in Cav1 and uses therefor
GB9824682D0 (en) * 1998-11-10 1999-01-06 Isis Innovation Bacillus strain and assay method
AU2030000A (en) 1998-11-25 2000-06-13 Cadus Pharmaceutical Corporation Methods and compositions for identifying receptor effectors
US6074845A (en) * 1999-01-28 2000-06-13 Smithkline Beecham Corporation Nucleic acid encoding a bovine calcitonin receptor-like receptor (BECRLR)
US6504008B1 (en) 1999-02-01 2003-01-07 Cadus Technologies, Inc. Cell based signal generation
US6555325B1 (en) 1999-06-14 2003-04-29 Cadus Technologies, Inc. System for detection of a functional interaction between a compound and a cellular signal transduction component
US7223533B2 (en) 1999-09-10 2007-05-29 Cadus Technologies, Inc. Cell surface proteins and use thereof as indicators of activation of cellular signal transduction pathways
JP2003521894A (ja) 1999-09-24 2003-07-22 ソルベイ・フアーマシユーチカルズ・ベー・ブイ 新規のヒトｇ−タンパク質共役型受容体
US6998255B1 (en) * 1999-09-24 2006-02-14 Solvay Pharmaceuticals B.V. Human G-protein coupled receptor
US20050148018A1 (en) 1999-10-07 2005-07-07 David Weiner Methods of identifying inverse agonists of the serotonin 2A receptor
AU3263101A (en) * 1999-11-24 2001-06-04 Millennium Pharmaceuticals, Inc. Expression cloning method
US7186505B1 (en) * 1999-11-29 2007-03-06 Stil Biotechnologies Ltd. Expression systems and methods for detecting and isolating polypeptides regulating signal transduction pathways
US7324236B2 (en) * 2000-02-01 2008-01-29 Canon Kabushiki Kaisha Discrepancy correction method and apparatus for correcting difference in levels of image signals obtained by an image sensor having a multiple output channels
US20050136431A1 (en) * 2000-11-03 2005-06-23 Oakley Robert H. Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
US7018812B2 (en) 2000-11-03 2006-03-28 Duke University Modified G-protein coupled receptors
US7163800B2 (en) * 2000-11-03 2007-01-16 Molecular Devices Corporation Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
CA2438212A1 (en) * 2001-02-08 2002-09-06 Temple University - Of The Commonwealth System Of Higher Education Biosensor for detecting chemical agents
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
US20030166540A1 (en) * 2001-05-30 2003-09-04 Feder John N. Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY30
US20030232359A1 (en) * 2002-03-18 2003-12-18 Ramanathan Chandra S. Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY40_2
US20030182669A1 (en) * 2002-03-19 2003-09-25 Rockman Howard A. Phosphoinositide 3-kinase mediated inhibition of GPCRs
US7290215B2 (en) * 2002-06-03 2007-10-30 Microsoft Corporation Dynamic wizard interface system and method
AU2003212136A1 (en) * 2003-03-07 2004-09-28 National Research Council Of Canada The determination of function of mammalian proteins by analysis of global gene expression profiles
US20050186658A1 (en) * 2003-10-17 2005-08-25 Nps Pharmaceuticals, Inc. Chimeric metabotropic glutamate receptors and uses thereof
WO2005055944A2 (en) 2003-12-05 2005-06-23 Cincinnati Children's Hospital Medical Center Oligosaccharide compositions and use thereof in the treatment of infection
AU2006220652A1 (en) 2005-03-07 2006-09-14 University Of Rochester Compositions and methods for inhibiting G protein signaling
GB0520568D0 (en) 2005-10-10 2005-11-16 Paradigm Therapeutics Ltd Receptor
CN109071626A (zh) 2016-02-24 2018-12-21 阿罗姆斯公司 用于检测气味、香味和味道的生物传感器
US10209239B1 (en) 2017-08-16 2019-02-19 Aromyx Corporation Method of making an aromagraph comprising ectopic olfactory receptors

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615974A (en) * 1981-08-25 1986-10-07 Celltech Limited Yeast expression vectors
US4865989A (en) * 1981-12-22 1989-09-12 U.C. Regents Eukaryotic vectors and plasmids having PGK regulatory signals
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
US4876197A (en) * 1983-02-22 1989-10-24 Chiron Corporation Eukaryotic regulatable transcription
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
NZ207926A (en) * 1983-04-25 1988-04-29 Genentech Inc Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast
US4797359A (en) * 1983-05-10 1989-01-10 Board Of Regents, The University Of Texas System Heat shock regulated production of selected and fused proteins in yeast
US4880734A (en) * 1984-05-11 1989-11-14 Chiron Corporation Eukaryotic regulatable transcription
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5071773A (en) 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US5378603A (en) 1987-03-30 1995-01-03 Board Of Regents, The University Of Texas System Method and composition for identifying substances which activate transcription of the LDL receptor gene
US4952499A (en) 1988-02-11 1990-08-28 Dana-Farber Cancer Institute Genes and their encoded proteins which regulate gene expression of the interleukin-2 receptor and of human lymphotropic retroviruses
FR2628750B1 (fr) * 1988-03-21 1991-11-08 Pasteur Institut Vecteur modifie par une sequence codant pour une sequence d'acides amines contenue dans une proteine de mammifere ayant une activite biologique de recepteur membranaire
EP0424397B1 (en) 1988-04-04 1996-06-19 The Salk Institute Biotechnology Industrial Associates, Inc. Calcium channel compositions and methods
US5407820A (en) 1988-04-04 1995-04-18 The Salk Institute Biotechnology/Industrial Associates, Inc. Calcium channel α-2 subunit DNAs and cells expressing them
US5386025A (en) 1990-02-20 1995-01-31 The Salk Institute Biotechnology/Industrial Associates Calcium channel compositions and methods
US5747336A (en) 1988-09-08 1998-05-05 The United States Of America As Represented By The Department Of Health And Human Services Cloned human genes for muscarinic acetylcholine receptors and cells lines expressing same
ATE154636T1 (de) * 1988-11-18 1997-07-15 Oregon State Dopamin-rezeptoren und gene
US5217867A (en) * 1988-11-30 1993-06-08 The Salk Institute For Biological Studies Receptors: their identification, characterization, preparation and use
AU660405B2 (en) 1989-07-18 1995-06-29 Osi Pharmaceuticals, Inc. Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators
US5665543A (en) 1989-07-18 1997-09-09 Oncogene Science, Inc. Method of discovering chemicals capable of functioning as gene expression modulators
US5284746A (en) 1990-02-08 1994-02-08 Zymogenetics, Inc. Methods of producing hybrid G protein-coupled receptors
US5369028A (en) 1990-04-03 1994-11-29 The Salk Institute Biotechnology/Industrial Associates, Inc. DNA and mRNA encoding human neuronal nicotinic acetylcholine receptor compositions and cells transformed with same
AU7686891A (en) * 1990-04-05 1991-10-30 American National Red Cross, The A protein family related to immediate-early protein expressed by human endothelial cells during differentiation
WO1991018005A1 (en) * 1990-05-14 1991-11-28 Duke University Cloned genes encoding the d1 dopamine receptor
US5426177A (en) 1990-06-01 1995-06-20 Regeneron Pharmaceuticals, Inc. Ciliary neurotrophic factor receptor
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
DK0548165T3 (da) * 1990-09-13 2001-07-16 Univ Duke Ekspression af G-proteinkoblede receptorer i gær
NZ240921A (en) * 1990-12-12 1994-06-27 Zymogenetics Inc G protein coupled glutamate receptor (neurotransmitters), recombinant production
US5384243A (en) * 1991-04-12 1995-01-24 The United States Of America As Represented By The Department Of Health And Human Services Method for screening an agent for its ability to prevent cell transformation
US5245011A (en) * 1991-04-16 1993-09-14 Duke University Aqueous solution containing D1B dopamine receptor
US5215915A (en) * 1991-04-16 1993-06-01 Duke University Cloned gene encoding rat d1b dopamine receptor
WO1992019723A1 (en) * 1991-04-29 1992-11-12 The Trustees Of Boston University Method of isolating ligands which bind neutrophil receptors
US5352660A (en) * 1991-10-31 1994-10-04 Mount Sinai Hospital Corporation Method for assaying for a substance that affects a SH2-phosphorylated ligand regulatory system
US5364791A (en) * 1992-05-14 1994-11-15 Elisabetta Vegeto Progesterone receptor having C. terminal hormone binding domain truncations
US5468615A (en) * 1993-07-01 1995-11-21 The Upjohn Company Binding assay employing a synthetic gene for D4 dopamine receptors

Also Published As

Publication number Publication date
JP2002253282A (ja) 2002-09-10
CA2092717A1 (en) 1992-03-14
GR3035937T3 (en) 2001-08-31
EP1029915A2 (en) 2000-08-23
DE69132546T2 (de) 2001-10-04
JP3348406B2 (ja) 2002-11-20
ATE199391T1 (de) 2001-03-15
JPH06500693A (ja) 1994-01-27
DE69132546D1 (de) 2001-04-05
IE913242A1 (en) 1992-02-25
US20030215887A1 (en) 2003-11-20
US6855550B2 (en) 2005-02-15
US5482835A (en) 1996-01-09
AU652576B2 (en) 1994-09-01
WO1992005244A1 (en) 1992-04-02
US20050214739A1 (en) 2005-09-29
CA2092717C (en) 2001-06-12
IE20020110A1 (en) 2003-05-28
US5739029A (en) 1998-04-14
US6168927B1 (en) 2001-01-02
DK0548165T3 (da) 2001-07-16
EP0548165A1 (en) 1993-06-30
JP2004000282A (ja) 2004-01-08
EP0548165A4 (en) 1993-08-11
EP1029915A3 (en) 2004-11-17
US7413876B2 (en) 2008-08-19
EP0548165B1 (en) 2001-02-28
US20020022238A1 (en) 2002-02-21
AU8511591A (en) 1992-04-15

Similar Documents

Publication Publication Date Title
ES2157197T3 (es) Expresion de receptores acoplados a una proteina g en levadura.
Leichtling et al. Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes
DE69636621D1 (de) Verwendung von chimären proteinen im transport von ausgewählten substanten in die zelle
EA200001023A1 (ru) Специфическое в отношении fapa-(протеин альфа активации фибробласта) антитело с повышенной продуктивностью
FI972390A0 (fi) Sytokiini nimeltä Lerk-7
ATE26464T1 (de) Rekombinante monoklonale antikoerper.
ATE177472T1 (de) Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen
EP0577605A4 (es)
UA41888C2 (uk) Злитий білок, який складається з мишачого або олюдненого моноклонального антитіла мав425 або його фрагменту, який спрямовано проти пухлинної клітини, спосіб його отримання, фармацевтична композиція
FI852547L (fi) Framstaellning av faktor viii och daertill hoerande produkter.
ES8506089A1 (es) Un procedimiento para preparar una celula u organismo recombinante
ATE198754T1 (de) Antikörper gegen saugetier-interleukin-4 und peptide verwendbar als antigenen für deren herstellung
ATE142645T1 (de) Rezeptoren für wachstumshormone
CU23238A1 (es) CéLULAS HUéSPED PARA LA EXPRESION DE UNA PROTEINA HETEROLOGA
ES2149167T3 (es) Factor transformante del crecimiento tipo beta.
BR1100650A (pt) Proteìnas de superfìcie cd44 variantes, sequências de dna que as codificam, anticorpos contra estas proteìnas, bem como a sua utilização no diagnóstico e na terapia
ES2072928T3 (es) Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular.
ATE142264T1 (de) Rekombinante herstellung von a-ketten- polypeptiden von pdgf
FR2669338B1 (es)
RU94046414A (ru) Моноклональные антитела к гликопротеину р, их получение и применение, продуцирующие их клетки, иммунологический диагностический набор на их основе, терапевтический состав
ATE107665T1 (de) Proteaseresistenter pdgf und dessen verwendungen.
GB2083836A (en) Monoclonal antibody
EP1702071A4 (en) TRANSACTIVATION SYSTEM FOR MAMMALIAN CELLS
DE3785673D1 (de) Monoklonaler antikoerper spezifisch gegen neutrophilen.
FR2744730B1 (fr) Nouvelle famille de canaux potassium de mammifere, leur clonage et leur utilisation notamment pour le criblage de drogues

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 548165

Country of ref document: ES